Thymulin Research Overview (also known as Facteur Thymique Serique, FTS, Serum Thymic Factor)
A zinc-dependent nonapeptide hormone secreted exclusively by thymic epithelial cells. Thymulin plays a central role in T-lymphocyte maturation and immune regulation, and its circulating levels decline sharply with age — paralleling the age-related involution of the thymus. Studied for immune restoration, autoimmune modulation, and anti-inflammatory applications.
What Is Thymulin?
Thymulin (formerly called Facteur Thymique Serique or FTS) is a nonapeptide — nine amino acids — produced and secreted exclusively by epithelial cells of the thymus gland. It is unique among thymic hormones in its absolute requirement for zinc: thymulin is biologically active only when complexed with zinc ions. Without zinc, the peptide circulates in an inactive form and cannot exert its immunological functions.
Role in T-Cell Biology
Thymulin's primary function is the induction of T-lymphocyte differentiation markers. It promotes the expression of T-cell surface antigens on immature thymocytes, enabling them to become mature, functional T-cells capable of mounting antigen-specific immune responses. It also modulates cytokine production, particularly suppressing pro-inflammatory cytokines while supporting regulatory T-cell activity — giving it an anti-inflammatory profile alongside its immunostimulatory role.
Age-Related Decline
Circulating thymulin levels peak in childhood and early adolescence, then decline progressively with thymic involution — falling dramatically after age 40 and becoming barely detectable in individuals over 60. This decline is considered a major contributor to immunosenescence: the progressive deterioration of immune function with aging. Restoring thymulin signaling is therefore of significant interest in aging and longevity research.
Therapeutic Research
Thymulin and synthetic analogs have been studied in models of autoimmune disease (including thyroiditis and lupus), chronic inflammation, and immune deficiency. Zinc co-administration is essential in research protocols because zinc deficiency renders any administered thymulin inactive.
Quick Reference
| Literature-Reported Dose Range | 1-5 mg (anecdotal) |
| Literature-Reported Frequency | Once daily for 5-10 days |
| Literature-Reported Cycle Length | 5-10 days |
| Literature-Reported Washout | Monthly to quarterly |
| Storage | Lyophilized: -20°C. Reconstituted: 2-8°C |
| Sites Reported in Studies | SubQ: Abdominal fat |
| Timing | Short half-life -daily dosing recommended |
Research Indications
Immunity
T-Cell Differentiation
Induces T-cell maturation and function in immature lymphoid cells
NK Cell Enhancement
Enhances natural killer cell activity
Inflammation
Cytokine Modulation
Inhibits TNF-α, IL-1β, IL-6 and other pro-inflammatory cytokines
NF-κB Inhibition
Blocks key inflammatory transcription factor
Anti-Aging
Thymic Support
May address age-related thymulin decline and immunosenescence
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
| Research Application | Dose | Frequency | Route |
|---|
| Immune Support (Anecdotal) | 1-5 mg | Once daily | SubQ |
| Animal Research | 15 μg/100g body weight | Per protocol | IP or SubQ |
Timing
Recommended administration window: short half-life -daily dosing recommended. Typical onset: immune effects may take weeks.
Peptide Interactions
These compounds address different research mechanisms represented in this preset. This is mechanistic complementarity, not evidence of clinical synergy: controlled studies of the exact combination are limited or unavailable, so interpret each exposure and safety signal independently.
Thymulin requires zinc for biological activity (1:1 equimolar binding). Zinc deficiency decreases thymulin activity; supplementation restores it. Co-administration essential for optimal effect.
Different functions -TB-4 focuses on tissue repair while thymulin modulates immune function. No known negative interactions.
Complementary anti-aging mechanisms. Epitalon targets telomerase/pineal function while thymulin addresses thymic/immune aging. Often used together in longevity protocols.
Both have anti-inflammatory effects but different mechanisms. High-dose corticosteroids may suppress thymic function. Thymulin may offer steroid-sparing potential in lung diseases.
PAT (thymulin analog) showed comparable efficacy to indomethacin in animal studies. Different mechanisms -may be additive for pain/inflammation.
Both have anti-inflammatory properties through different pathways. No interaction studies available. Theoretically compatible.
Both involved in aging-related pathways. Different mechanisms. No interaction data available.
Reported Research Timeline
01No immediate effects expected
02Immune improvements may take weeks
03Best results with adequate zinc status
04Multiple cycles may be needed
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
Requires zinc for biological activity
Very short serum half-life (~10 min)
No toxicity in preclinical studies
Limited human data -research only
Seek Medical Attention If:
Unexpected systemic effects
Quality Indicators
Acceptable Range
Zinc dependency
Requires zinc for biological activity. Supplement if needed.
Acceptable Range
Very short half-life
Serum half-life only ~10 minutes.
Verified Marker
Excellent preclinical safety
No toxicity observed in animal studies.
Research Citations
- Interactions between zinc and thymulin
Dardenne, M., Pleau, J.M., 1994, Metal-Based Drugs - Potent analgesic and anti-inflammatory actions of a novel thymulin-related peptide in the rat
Safieh-Garabedian, B., Poole, S., Allchorne, A., Kanaan, S., Saade, N., Bhutto, B., 2002, British Journal of Pharmacology - A thymulin analogue peptide with powerful inhibitory effects on pain of neurogenic origin
Safieh-Garabedian, B., Kanaan, S.A., Jalakhian, R.H., Poole, S., Jabbur, S.J., Saade, N.E., 2003, Neuroscience - Immunomodulatory role of thymulin in lung diseases
Savino, W., Dardenne, M., 2010, Annals of the New York Academy of Sciences - Thymus hormones as prospective anti-inflammatory agents
Lunin, S.M., Novoselova, E.G., 2010, Expert Opinion on Therapeutic Targets - Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging
Thomas-Vaslin, V., Cumberland, R., Goldrath, A.W., et al., 2020, Immunity & Ageing - Physiology and therapeutic potential of the thymic peptide thymulin
Reggiani PC, Schwerdt JI, Console GM, 2014, Curr Pharm Des - Thymulin and the neuroendocrine system
Goya RG, Brown OA, Pléau JM, 2004, Peptides - The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin
Reggiani PC, Morel GR, Cónsole GM, 2009, Ann N Y Acad Sci - Thymus-derived hormonal and cellular control of cancer
Savino W, Lepletier A, 2023, Front Endocrinol (Lausanne) - Protective effect of exogenous peroxiredoxin 6 and thymic peptide thymulin on BBB conditions in an experimental model of multiple sclerosis
Lunin SM, Novoselova EG, Glushkova OV, 2023, Arch Biochem Biophys
Research Focus
T-cell maturation, Immune restoration, Anti-inflammatory, Autoimmune modulation, Thymic function
Verified Vendors Carrying Thymulin
Frequently Asked Questions
What should researchers watch for with Thymulin?
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
What should researchers expect over time with Thymulin?
No immediate effects expected
How is Thymulin typically administered in research?
As reported in cited literature and research-community logs (see Research Citations below) — not a personal dosing recommendation.
Browse all peptides in the Encyclopedia →